Multisite cardiac resynchronization therapy for traditional and non-traditional indications
ConclusionsMSCRT is feasible, safe, and valuable in selected patients with a need to avoid RV lead during device implantation, refractory VT with no other solution, severe HFrEF with wide QRS or CRT non-responsiveness, and severe HF without LBBB. Randomized controlled studies are required.
Source: Journal of Interventional Cardiac Electrophysiology - Category: Cardiology Source Type: research
More News: Cardiac Resynchronization Therapy | Cardiology | Disability | Heart | Heart Failure | Heart Valve Surgery | Renal Failure | Study | Ventricular Tachycardia